Nektar Therapeutics (NKTR)

May 25, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nektar Therapeutics (NKTR) And Encourages Stockholders to Connect - ACCESS Newswire

May 25, 2026

May 24, 2026

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch - AOL.com

May 24, 2026

May 24, 2026

A Look At Nektar Therapeutics (NKTR) Valuation After Prosight’s US$10 Million Purchase Ahead Of Phase 3 Trial - simplywall.st

May 24, 2026

May 23, 2026

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch - The Motley Fool

May 23, 2026

May 22, 2026

Nektar TherapeuticsCommon Stock (NQ: NKTR - The Chronicle-Journal

May 22, 2026

May 21, 2026

Nektar Therapeutics R&D chief sells $13,036 in shares - Investing.com UK

May 21, 2026

May 21, 2026

Nektar Therapeutics CEO Robin Howard W sells $29,086 in shares By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

Nektar Therapeutics R&D chief sells $13,036 in shares By Investing.com - Investing.com Canada

May 21, 2026

May 21, 2026

Nektar Therapeutics CEO Robin Howard W sells $29,086 in shares - Investing.com

May 21, 2026

May 21, 2026

Nektar Therapeutics (NKTR) R&D chief sells shares to cover RSU tax - Stock Titan

May 21, 2026

May 21, 2026

Nektar Therapeutics (NKTR) CEO logs small 444-share tax-related stock sale - Stock Titan

May 21, 2026

May 21, 2026

Is Nektar Therapeutics’ (NKTR) New CFO Hire and Equity Program Reframing Its Capital-Market Strategy? - simplywall.st

May 21, 2026

May 20, 2026

Nektar Q1 earnings & revenues lag estimates, pipeline in focus - MSN

May 20, 2026

May 20, 2026

NKTR Stock Chart | NEKTAR THERAPEUTICS (NASDAQ:NKTR) - ChartMill

May 20, 2026

May 19, 2026

Nektar Names Linda Rubinstein CFO As Funding And Dilution Questions Loom - simplywall.st

May 19, 2026

May 19, 2026

[144] NEKTAR THERAPEUTICS SEC Filing - Stock Titan

May 19, 2026

May 19, 2026

Why Nektar Therapeutics Stock Rocked it Today - MSN

May 19, 2026

May 17, 2026

Nektar Therapeutics stock (US6354171056): FDA update and pipeline focus - AD HOC NEWS

May 17, 2026

May 17, 2026

Patient Square Capital LP Acquires 210,000 Shares of Nektar Therapeutics in Q1 2026News and Statistics - IndexBox

May 17, 2026

May 16, 2026

Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares - AOL.com

May 16, 2026

May 15, 2026

BVF Group (NKTR) reports up to 2.85M shares—9.8% aggregate holding - Stock Titan

May 15, 2026

May 15, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 15, 2026

May 15, 2026

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR) - The Globe and Mail

May 15, 2026

May 14, 2026

Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $151 - 富途牛牛

May 14, 2026

May 14, 2026

Nektar Therapeutics stock (US6354171056): $400M capital raise fuels Phase 3 autoimmune pipeline - AD HOC NEWS

May 14, 2026

May 14, 2026

NKTR Stock Price, Quote & Chart | NEKTAR THERAPEUTICS (NASDAQ:NKTR) - ChartMill

May 14, 2026

May 13, 2026

Assessing Nektar Therapeutics (NKTR) Valuation After Its Recent Share Price Recovery - simplywall.st

May 13, 2026

May 12, 2026

Assessing Nektar Therapeutics (NKTR) Valuation After Strong REZPEG Prospects And Recent Share Price Momentum - Yahoo Finance

May 12, 2026

May 12, 2026

Nektar Therapeutics Raises $374 Million After Alopecia Data Release; AnaptysBio’s First Tracks Bio Debuts on NASDAQ - geneonline.com

May 12, 2026

May 11, 2026

Why Nektar Therapeutics Shares Are Sliding Now - TipRanks

May 11, 2026

May 11, 2026

Nektar Therapeutics adds to its 129% two-month run with alopecia news - MSN

May 11, 2026

May 11, 2026

H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $185 - 富途牛牛

May 11, 2026

May 11, 2026

Earnings Update: Here's Why Analysts Just Lifted Their Nektar Therapeutics (NASDAQ:NKTR) Price Target To US$153 - simplywall.st

May 11, 2026

May 11, 2026

Nektar Therapeutics (NASDAQ:NKTR) Analysts Are Pretty Bullish On The Stock After Recent Results - 富途牛牛

May 11, 2026

May 09, 2026

A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $134 to $185 - Moomoo

May 09, 2026

May 09, 2026

Nektar posts 52-week data from mid-stage trial for hair loss therapy - msn.com

May 09, 2026

May 08, 2026

Nektar Therapeutics Enters Equity Distribution Agreement with Guggenheim Securities and H.C. Wainwright – 8-K Filing Details 27 - Minichart

May 08, 2026

May 08, 2026

Nektar Therapeutics Charts Aggressive Path With REZPEG - TipRanks

May 08, 2026

May 08, 2026

Nektar Therapeutics Names Rubinstein New Interim CFO - Moomoo

May 08, 2026

May 08, 2026

Nektar Therapeutics Establishes New Equity Distribution Agreement - TipRanks

May 08, 2026

May 08, 2026

Nektar Therapeutics announces $150 million equity distribution agreement and CFO transition - Investing.com Australia

May 08, 2026

May 08, 2026

Nektar Therapeutics announces $150 million equity distribution agreement and CFO transition By Investing.com - Investing.com South Africa

May 08, 2026